Publication & Citation Trends
Publications
0 total
A multivalent RSV vaccine based on the Modified Vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a Phase 3 clinical study OA
Cited by 11
Semantic Scholar
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine OA
Cited by 28
Semantic Scholar
Decreased Viral Load, Symptom Reduction, and Prevention of Respiratory Syncytial Virus Infection with MVA-BN-RSV Vaccine OA
Cited by 2
Semantic Scholar
LENZILUMAB OUTCOMES ACCORDING TO RACE OF COVID-19 PARTICIPANTS IN THE LIVE-AIR PHASE 3 TRIAL OA
Cited by 0
Semantic Scholar
LB747. Immune Responses of the Recombinant MVA-BN-RSV Vaccine against Respiratory Syncytial Virus Infection in an RSV Human Challenge Trial (HCT) in Healthy Adult Participants OA
Cited by 0
Semantic Scholar
Broad Antibody and Cellular Immune Response from a Phase 2 Clinical Trial with a Novel Multivalent Poxvirus Based RSV Vaccine.
Cited by 48
Semantic Scholar
Research Topics
Bacteriophages and microbial interactions
(4)
Genetics, Bioinformatics, and Biomedical Research
(4)
Bacterial Genetics and Biotechnology
(2)
RNA and protein synthesis mechanisms
(2)
Forensic and Genetic Research
(2)
Affiliations
National Institutes of Health
Harvard University
Johns Hopkins University
University of Cologne
Harvard University Press